Prevalence of haemochromatosis gene mutations in Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 3, 2007, Pages 315-317

  Aamodt, Anne Hege ^a,b   Stovner, Lars Jacob ^a   Thorstensen, Ketil ^b   Lydersen, Stian ^c   White, Linda R ^a   Aasly, Jan O ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC DISORDER; GENOTYPE; HEMOCHROMATOSIS; HUMAN; IRON ABSORPTION; IRON BLOOD LEVEL; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; NORWAY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE;

HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; IRON; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

BASAL GANGLIA; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MALE; MEMBRANE PROTEINS; NORWAY; PARKINSON DISEASE; PREVALENCE;

EID: 33847734350     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.101352     Document Type: Article

References (19)

1. Costello DJ, Walsh SL, Harrington HI, et al. Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series. J Neurol Neurosurg Psychiatry 2004;75:631-3.
2. Demarquay G, Setiey A, Morel Y, et al. Clinical report of three patients with hereditary hemochromatosis and movement disorders. Mov Disord 2000;15:1204-9.
3. Thomas M, Jankovic J. Neurodegenerative disease and iron storage in the brain. Curr Opin Neurol 2004;17:437-42.
4. Dekker MC, Giesbergen PC, Njajou OT, et al. Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism. Neurosci Lett 2003;348:117-19.
5. Berg D, Hoggenmuller U, Hofmann E, et al. The basal ganglia in haemochromatosis. Neuroradiology 2000;42:9-13.
6. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998;339:1044-53.
7. Hirsch EC, Faucheux BA. Iron metabolism and Parkinson's disease. Mov Disord 1998;13(Suppl 1):39-45.
8. Faucheux BA, Martin ME, Beaumont C, et al. Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. J Neurochem 2003;86:1142-8.
9. Åsberg A, Hveem K, Thorstensen K, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108- 15.
10. Fairbanks VF, Brandhagen DJ. Disorders of iron storage and transport. In: Beutler E, Lichtmann MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams hematology.6th edn. New York: McGraw-Hill, 2001:489-502.
11. Borie C, Gasparini F, Verpillat P, et al. Association study between iron-related genes polymorphisms and Parkinson's disease. J Neurol 2002;249:801-4.
12. Buchanan DD, Silburn PA, Chalk JB, et al. The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients. Neurosci Lett 2002;327:91-4.
13. Aasly JO, Toft M, Fernandez-Mata I, et al. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Ann Neurol 2005;57:762-5.
14. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-9.
15. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
16. Mura C, Raguenes O, Férec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999;93:2502-5.
17. Distante S, Berg JP, Lande K, et al. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand J Gastroenterol 1999;34:529-34.
18. Hirji KF, ed.Exact analysis of discrete data. Exact analysis of discrete data. London: Chapman & Hall, 2006:218-19.
19. White AR, Barnham KJ, Huang X, et al. Iron inhibits neurotoxicity induced by trace copper and biological reauctants. J Biol Inorg Chem 2004;9:269-80.